Abstract
Summary
LPI (LP Information)' newest research report, the “Drug Discovery Assays Industry Forecast” looks at past sales and reviews total world Drug Discovery Assays sales in 2022, providing a comprehensive analysis by region and market sector of projected Drug Discovery Assays sales for 2023 through 2029. With Drug Discovery Assays sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Discovery Assays industry.
This Insight Report provides a comprehensive analysis of the global Drug Discovery Assays landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug Discovery Assays portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drug Discovery Assays market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Discovery Assays and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Discovery Assays.
The global Drug Discovery Assays market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Drug Discovery Assays is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Drug Discovery Assays is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Drug Discovery Assays is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Drug Discovery Assays players cover Thermo Fisher Scientific, Danaher, Becton Dickinson, GE Healthcare, Merck, Lonza, PerkinElmer, Inc., Charles River Laboratories, Inc. and Cell Signaling Technologies, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Discovery Assays market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Consumables
Instruments
Services
Software
Segmentation by application
Pharmaceutical and Biotechnology Companies
Academic and Government Institutions
Contract Research Organizations
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Danaher
Becton Dickinson
GE Healthcare
Merck
Lonza
PerkinElmer, Inc.
Charles River Laboratories, Inc.
Cell Signaling Technologies
Cisbio
Cell Biolabs, Inc.
Promega
This Insight Report provides a comprehensive analysis of the global Drug Discovery Assays landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug Discovery Assays portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drug Discovery Assays market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Discovery Assays and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Discovery Assays.
The global Drug Discovery Assays market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Drug Discovery Assays is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Drug Discovery Assays is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Drug Discovery Assays is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Drug Discovery Assays players cover Thermo Fisher Scientific, Danaher, Becton Dickinson, GE Healthcare, Merck, Lonza, PerkinElmer, Inc., Charles River Laboratories, Inc. and Cell Signaling Technologies, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Discovery Assays market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Consumables
Instruments
Services
Software
Segmentation by application
Pharmaceutical and Biotechnology Companies
Academic and Government Institutions
Contract Research Organizations
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Danaher
Becton Dickinson
GE Healthcare
Merck
Lonza
PerkinElmer, Inc.
Charles River Laboratories, Inc.
Cell Signaling Technologies
Cisbio
Cell Biolabs, Inc.
Promega
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drug Discovery Assays Market Size 2018-2029
2.1.2 Drug Discovery Assays Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Drug Discovery Assays Segment by Type
2.2.1 Consumables
2.2.2 Instruments
2.2.3 Services
2.2.4 Software
2.3 Drug Discovery Assays Market Size by Type
2.3.1 Drug Discovery Assays Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Drug Discovery Assays Market Size Market Share by Type (2018-2023)
2.4 Drug Discovery Assays Segment by Application
2.4.1 Pharmaceutical and Biotechnology Companies
2.4.2 Academic and Government Institutions
2.4.3 Contract Research Organizations
2.4.4 Others
2.5 Drug Discovery Assays Market Size by Application
2.5.1 Drug Discovery Assays Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Drug Discovery Assays Market Size Market Share by Application (2018-2023)
3 Drug Discovery Assays Market Size by Player
3.1 Drug Discovery Assays Market Size Market Share by Players
3.1.1 Global Drug Discovery Assays Revenue by Players (2018-2023)
3.1.2 Global Drug Discovery Assays Revenue Market Share by Players (2018-2023)
3.2 Global Drug Discovery Assays Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Drug Discovery Assays by Regions
4.1 Drug Discovery Assays Market Size by Regions (2018-2023)
4.2 Americas Drug Discovery Assays Market Size Growth (2018-2023)
4.3 APAC Drug Discovery Assays Market Size Growth (2018-2023)
4.4 Europe Drug Discovery Assays Market Size Growth (2018-2023)
4.5 Middle East & Africa Drug Discovery Assays Market Size Growth (2018-2023)
5 Americas
5.1 Americas Drug Discovery Assays Market Size by Country (2018-2023)
5.2 Americas Drug Discovery Assays Market Size by Type (2018-2023)
5.3 Americas Drug Discovery Assays Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Discovery Assays Market Size by Region (2018-2023)
6.2 APAC Drug Discovery Assays Market Size by Type (2018-2023)
6.3 APAC Drug Discovery Assays Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Drug Discovery Assays by Country (2018-2023)
7.2 Europe Drug Discovery Assays Market Size by Type (2018-2023)
7.3 Europe Drug Discovery Assays Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drug Discovery Assays by Region (2018-2023)
8.2 Middle East & Africa Drug Discovery Assays Market Size by Type (2018-2023)
8.3 Middle East & Africa Drug Discovery Assays Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Drug Discovery Assays Market Forecast
10.1 Global Drug Discovery Assays Forecast by Regions (2024-2029)
10.1.1 Global Drug Discovery Assays Forecast by Regions (2024-2029)
10.1.2 Americas Drug Discovery Assays Forecast
10.1.3 APAC Drug Discovery Assays Forecast
10.1.4 Europe Drug Discovery Assays Forecast
10.1.5 Middle East & Africa Drug Discovery Assays Forecast
10.2 Americas Drug Discovery Assays Forecast by Country (2024-2029)
10.2.1 United States Drug Discovery Assays Market Forecast
10.2.2 Canada Drug Discovery Assays Market Forecast
10.2.3 Mexico Drug Discovery Assays Market Forecast
10.2.4 Brazil Drug Discovery Assays Market Forecast
10.3 APAC Drug Discovery Assays Forecast by Region (2024-2029)
10.3.1 China Drug Discovery Assays Market Forecast
10.3.2 Japan Drug Discovery Assays Market Forecast
10.3.3 Korea Drug Discovery Assays Market Forecast
10.3.4 Southeast Asia Drug Discovery Assays Market Forecast
10.3.5 India Drug Discovery Assays Market Forecast
10.3.6 Australia Drug Discovery Assays Market Forecast
10.4 Europe Drug Discovery Assays Forecast by Country (2024-2029)
10.4.1 Germany Drug Discovery Assays Market Forecast
10.4.2 France Drug Discovery Assays Market Forecast
10.4.3 UK Drug Discovery Assays Market Forecast
10.4.4 Italy Drug Discovery Assays Market Forecast
10.4.5 Russia Drug Discovery Assays Market Forecast
10.5 Middle East & Africa Drug Discovery Assays Forecast by Region (2024-2029)
10.5.1 Egypt Drug Discovery Assays Market Forecast
10.5.2 South Africa Drug Discovery Assays Market Forecast
10.5.3 Israel Drug Discovery Assays Market Forecast
10.5.4 Turkey Drug Discovery Assays Market Forecast
10.5.5 GCC Countries Drug Discovery Assays Market Forecast
10.6 Global Drug Discovery Assays Forecast by Type (2024-2029)
10.7 Global Drug Discovery Assays Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific Drug Discovery Assays Product Offered
11.1.3 Thermo Fisher Scientific Drug Discovery Assays Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Danaher
11.2.1 Danaher Company Information
11.2.2 Danaher Drug Discovery Assays Product Offered
11.2.3 Danaher Drug Discovery Assays Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Danaher Main Business Overview
11.2.5 Danaher Latest Developments
11.3 Becton Dickinson
11.3.1 Becton Dickinson Company Information
11.3.2 Becton Dickinson Drug Discovery Assays Product Offered
11.3.3 Becton Dickinson Drug Discovery Assays Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Becton Dickinson Main Business Overview
11.3.5 Becton Dickinson Latest Developments
11.4 GE Healthcare
11.4.1 GE Healthcare Company Information
11.4.2 GE Healthcare Drug Discovery Assays Product Offered
11.4.3 GE Healthcare Drug Discovery Assays Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 GE Healthcare Main Business Overview
11.4.5 GE Healthcare Latest Developments
11.5 Merck
11.5.1 Merck Company Information
11.5.2 Merck Drug Discovery Assays Product Offered
11.5.3 Merck Drug Discovery Assays Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Merck Main Business Overview
11.5.5 Merck Latest Developments
11.6 Lonza
11.6.1 Lonza Company Information
11.6.2 Lonza Drug Discovery Assays Product Offered
11.6.3 Lonza Drug Discovery Assays Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Lonza Main Business Overview
11.6.5 Lonza Latest Developments
11.7 PerkinElmer, Inc.
11.7.1 PerkinElmer, Inc. Company Information
11.7.2 PerkinElmer, Inc. Drug Discovery Assays Product Offered
11.7.3 PerkinElmer, Inc. Drug Discovery Assays Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 PerkinElmer, Inc. Main Business Overview
11.7.5 PerkinElmer, Inc. Latest Developments
11.8 Charles River Laboratories, Inc.
11.8.1 Charles River Laboratories, Inc. Company Information
11.8.2 Charles River Laboratories, Inc. Drug Discovery Assays Product Offered
11.8.3 Charles River Laboratories, Inc. Drug Discovery Assays Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Charles River Laboratories, Inc. Main Business Overview
11.8.5 Charles River Laboratories, Inc. Latest Developments
11.9 Cell Signaling Technologies
11.9.1 Cell Signaling Technologies Company Information
11.9.2 Cell Signaling Technologies Drug Discovery Assays Product Offered
11.9.3 Cell Signaling Technologies Drug Discovery Assays Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Cell Signaling Technologies Main Business Overview
11.9.5 Cell Signaling Technologies Latest Developments
11.10 Cisbio
11.10.1 Cisbio Company Information
11.10.2 Cisbio Drug Discovery Assays Product Offered
11.10.3 Cisbio Drug Discovery Assays Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Cisbio Main Business Overview
11.10.5 Cisbio Latest Developments
11.11 Cell Biolabs, Inc.
11.11.1 Cell Biolabs, Inc. Company Information
11.11.2 Cell Biolabs, Inc. Drug Discovery Assays Product Offered
11.11.3 Cell Biolabs, Inc. Drug Discovery Assays Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Cell Biolabs, Inc. Main Business Overview
11.11.5 Cell Biolabs, Inc. Latest Developments
11.12 Promega
11.12.1 Promega Company Information
11.12.2 Promega Drug Discovery Assays Product Offered
11.12.3 Promega Drug Discovery Assays Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Promega Main Business Overview
11.12.5 Promega Latest Developments
12 Research Findings and Conclusion